Parks RJ - Search Results

1

Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic.

Del Papa J, Clarkin RG, Parks RJ. Del Papa J, et al. Among authors: parks rj. Cancer Gene Ther. 2021 Aug;28(7-8):745-756. doi: 10.1038/s41417-020-0192-9. Epub 2020 Jul 1. Cancer Gene Ther. 2021. PMID: 32606392 Review.

2

Adenoviral vectors: prospects for gene delivery to the central nervous system.

Parks RJ, Bramson JL. Parks RJ, et al. Gene Ther. 1999 Aug;6(8):1349-50. doi: 10.1038/sj.gt.3301013. Gene Ther. 1999. PMID: 10467358 No abstract available.

3

Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.

Parks R, Evelegh C, Graham F. Parks R, et al. Gene Ther. 1999 Sep;6(9):1565-73. doi: 10.1038/sj.gt.3300995. Gene Ther. 1999. PMID: 10490766

4

Helper-dependent adenovirus vectors: their use as a gene delivery system to neurons.

Cregan SP, MacLaurin J, Gendron TF, Callaghan SM, Park DS, Parks RJ, Graham FL, Morley P, Slack RS. Cregan SP, et al. Among authors: parks rj. Gene Ther. 2000 Jul;7(14):1200-9. doi: 10.1038/sj.gt.3301208. Gene Ther. 2000. PMID: 10918488

5

Cancer therapy utilizing an adenoviral vector expressing only E1A.

Hubberstey AV, Pavliv M, Parks RJ. Hubberstey AV, et al. Among authors: parks rj. Cancer Gene Ther. 2002 Apr;9(4):321-9. doi: 10.1038/sj.cgt.7700436. Cancer Gene Ther. 2002. PMID: 11960282

6

Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implications for spinal muscular atrophy therapy.

DiDonato CJ, Parks RJ, Kothary R. DiDonato CJ, et al. Among authors: parks rj. Hum Gene Ther. 2003 Jan 20;14(2):179-88. doi: 10.1089/104303403321070874. Hum Gene Ther. 2003. PMID: 12614569

7

Oncolytic adenovirus: getting there is half the battle.

Ross PJ, Parks RJ. Ross PJ, et al. Among authors: parks rj. Mol Ther. 2003 Nov;8(5):705-6. doi: 10.1016/j.ymthe.2003.09.005. Mol Ther. 2003. PMID: 14632023 Free article. No abstract available.

8

Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.

Sargent KL, Ng P, Evelegh C, Graham FL, Parks RJ. Sargent KL, et al. Among authors: parks rj. Gene Ther. 2004 Mar;11(6):504-11. doi: 10.1038/sj.gt.3302107. Gene Ther. 2004. PMID: 14999222

9

Adenovirus protein IX: a new look at an old protein.

Parks RJ. Parks RJ. Mol Ther. 2005 Jan;11(1):19-25. doi: 10.1016/j.ymthe.2004.09.018. Mol Ther. 2005. PMID: 15585402 Free article. Review.

10

Rational design of murine secreted alkaline phosphatase for enhanced performance as a reporter gene in mouse gene therapy preclinical studies.

Christou C, Parks RJ. Christou C, et al. Among authors: parks rj. Hum Gene Ther. 2011 Apr;22(4):499-506. doi: 10.1089/hum.2010.171. Epub 2011 Mar 4. Hum Gene Ther. 2011. PMID: 21083426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page